Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

291

Participants

Timeline

Start Date

June 1, 2015

Primary Completion Date

November 1, 2016

Study Completion Date

December 1, 2016

Conditions
Hypotension on Induction
Interventions
DRUG

ACEI continuation

These chronic medications will be taken without interruption preoperatively.

DRUG

ACEI omission

Although taken chronically by patients in this intervention, the final preoperative dose of these medications will be omitted, whether it was scheduled for the morning of surgery or the day prior.

Trial Locations (1)

68198

University of Nebraska Medical Center, Omaha

All Listed Sponsors
lead

University of Nebraska

OTHER

NCT01669434 - Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery | Biotech Hunter | Biotech Hunter